Pfizer has withdrawn a drug at risk for cancer

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

Pfizer has dropped the anti-cancer drug Chantix due to the risk of cancer. reports this step was taken due to the high content of cancer-causing substances in the pills.

Experts from the Food and Drug Administration of the US Department of Health and Human Services have come to this conclusion.

Studies show that long-term use of the drug increases the risk of cancer.

2021.09.19 / 18:31
See also

Warning from scientists about a new mutation

AstraZeneca antibody shot prevents severe Covid - trial

WHO backs rollout of malaria vaccine for African children

UNICEF: 1 in 7 young people suffer from mental disorders

China administers over 2 bln COVID-19 vaccine doses

EU and AstraZeneca reach deal to end vaccine row

A new strain of the coronavirus is spreading - WHO

Delta variant patients twice as likely need hospital care

5 billion doses of vaccine have been given worldwide

Pfizer COVID-19 vaccine wins full U.S. FDA approval

Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla